Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.50
Bid: 237.50
Ask: 238.50
Change: 3.50 (1.50%)
Spread: 1.00 (0.421%)
Open: 233.00
High: 238.50
Low: 230.50
Prev. Close: 234.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

Tue, 16th Apr 2024 21:57

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value was 39.7 pence per share at February 29, down from 45.3 pence at February 28, 2023. Chair says: "In a year when the FTSE AIM All Share Index declined by 14%, your company made a loss of GBP1.75 million with net assets down by 19%" and that this year's results "can only be described as disappointing". Declares 55.0p dividend for the year to February 29, unchanged from the year before. Says it now has "the critical mass we have been seeking for a long time", and that it is currently seeking alternative plans to manage its rump portfolio once its primary assets have been realised.

----------

Petra Diamonds Ltd - Bermuda-based diamond mining group - Says revenue for the third quarter of financial 2024 totalled USD66 million, down from USD90 million in the second quarter. Says the decrease was due to lower production and the timing of receipts from Tender 5. Says this fifth tender cycle yielded USD49 million from the sale of 362,132 carats at an average price of USD136 per carat. This compares with USD48 million from 428,860 carats at USD112 per carat in the fourth tender cycle. Says production for the quarter was consistent with the preceding three months and in line with expectations. Total tonnes treated decreased 1.5% to 2.9 million tonnes from 3.0 million tonnes.

----------

J Smart & Co (Contractors) PLC - Edinburgh-based construction contractor - Pretax profit for the six months to January 31 falls 21% to GBP205,000 from GBP260,000 the year before. Revenue however rises 54% to GBP8.6 million from GBP5.6 million. Company declares 0.96p per share interim dividend, unchanged year-on-year. Cost of sales rises to GBP6.4 million from GBP2.1 million. Company says construction material prices "are still rising, which continues to affect the viability of all types of potential projects". Says there has been a "slight improvement" on limited reservations compared to in late 2023, but continuing economic issues are still affecting consumer sentiment. Says lettings remain "robust" but that in the year to July 31 "there will definitely be profit erosion due to lack of external contracts, the lack of recovery of overhead costs, the continued increase in material costs, prolonged programmes due to utility infrastructure and statutory authority delays and the cost of holding private housing stock".

----------

Tertiary Minerals PLC - mineral development company focused on deposits in the US, Zambia and Northern Europe - Announces that drilling is now underway at the Konkola West Copper Project in Zambia. The project "is targeting projected deep down-dip and along-strike extensions of the contiguous Lubambe-Mingomba-Konkola copper deposits to the east of the licence and which extend north into the Musoshi mining complex in the Democratic Republic of the Congo". The long continuous zone of mineralisation is 15 kilometres total and contained a pre-mining endowment of over 775 million tonnes of copper graded at between 2% and 3%.

----------

PureTech Health PLC - London-based biotherapeutics company - Completes enrolment in the Elevate IPF Phase 2b clinical trial, which will evaluate LYT-100 or deupirfenidone in patients with idiopathic pulmonary fibrosis or IPF. Says LYT-100 is a deuterated form of pirfenidone, one of the two standard-of-care treatments approved to treat IPF. The randomised double-blind trial will measure as primary endpoint the rate of decline in forced vital capacity for the combined LYT-100 arms versus the placebo group over 26 weeks. Says other key endpoints will include tolerability measures, biomarkers and patient-reported outcomes. Expects topline results in the fourth quarter of 2024.

----------

DP Poland PLC - London-based operator of Domino's pizza stores and restaurants in Poland and Croatia - Raises gross GBP1 million pursuant to oversubscribed retail offer, with 10.1 million shares to be issued as a result. Says it has raised around GBP20.5 million in total from subscription, placing and retail offer combined. Fundraise was announced in late March, with placing price of 9.92p per share. This included a GBP11 million investment from Domino's Pizza Group PLC.

----------

Golden Metal Resources PLC - Nevada-focused metals exploration company - Says ground magnetic survey has detected significant anomalies at its Garfield project in Nevada's Walker Lane Mineral Belt. Says two magnetic anomalies were detected within the 'High-Grade' zone, and another was located in the southwestern part of the 'Power-Line' zone. Says it is "very encouraged" by the results, and has commissioned a ground magnetic geophysics survey across some of the main target areas at Pilot Mountain. Results are currently being processed. Adds that drilling preparations for Pilot Mountain are "well underway" and expects to receive permits "imminently". Chief Executive Officer Oliver Friesen says 2024 "is shaping up to be a very exciting year for Golden Metal", which is "positioned perfectly to address" the increasing demand for "important metals such as tungsten".

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
8 Jul 2020 15:13

Peel Hunt says Vor Biopharma cash call validates Puretech Health's model

(Sharecast News) - Analysts at Peel Hunt reiterated their 'Conviction Buy' recommendation for shares of PureTech Health following a $110.0m funding round for its founded entity Vor Biopharma, arguing that the transaction validated its business model.

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
23 Jun 2020 07:29

PureTech's Akili gets CE-mark for 'EndeavourRx'

(Sharecast News) - Biotherapeutics company PureTech Health said its founded entity Akili had received a CE-mark for 'EndeavorRx treatment for attention deficit hyperactivity disorder (ADHD).

Read more
18 Jun 2020 18:49

IN BRIEF: Puretech Health Partners With China Medical System

IN BRIEF: Puretech Health Partners With China Medical System

Read more
16 Jun 2020 14:34

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

Read more
16 Jun 2020 07:29

PureTech gets FDA clearance for video game ADHD treatment

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that its subsidiary Akili has been granted US Food and Drug Administration (FDA) clearance for 'EndeavorRx', or AKL-T01, as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).

Read more
9 Jun 2020 13:25

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

Read more
9 Jun 2020 08:40

PureTech Health sees 'positive' topline data from Phase 1 on IBD candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health reported some "positive" topline data from two Phase 1 studies into VE202, its orally-administered inflammatory bowel disease treatment candidate.

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 07:37

PureTech firm Gelesis gets Europe approval for 'Plenity'

(Sharecast News) - Clinical stage biotherapeutics company PureTech Health announced on Tuesday that its founded company Gelesis has received approval to market 'Plenity', a novel weight-loss treatment, in Europe.

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
28 May 2020 07:57

PureTech to advance LYT-100 as potential Covid treatment

(Sharecast News) - PureTech Health announced plans on Thursday to advance its wholly-owned clinical-stage product candidate 'LYT-100', or deupirfenidone, as a potential treatment for serious respiratory complications, including inflammation and fibrosis, that persist following the resolution of Covid-19 infection.

Read more
26 May 2020 14:22

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Read more
26 May 2020 08:51

PureTech Health lowers stake in founded entity

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.